| abstract |
THE INVENTION REFERS TO 17µ- FLUOROSTEROIDS OF THE GENERAL FORMULA WHERE R1 IS A HYDROGEN ATOM OR A METHYL HRUP, R2 and R3 ARE A HYDROGEN ATOM, A CHLORINE ATOM OR A METHYL GROUP AND AMONG CARBON ATOMS 7 THERE CAN BE A SIMPLE OR DOUBLE UNION AND BETWEEN CARBON ATOMS 9 AND 10 THERE CAN BE A SIMPLE OR DOUBLE UNION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. THE COMPOUNDS OF THE INVENTION HAVE A HYBRID CHARACTER EFFECT PROFILE, AS THEY ACT AS INHIBITORS OF 5µ-REDUCTASE AND AT THE SAME TIME AS A GREAT POWER GESTAGEN. THEREFORE, THEY ARE APPROPRIATE FOR THE TREATMENT OF DISEASES ORIGINATED IN CERTAIN ORGANS AND FABRICS OF MAN AND WOMEN AS A CONSEQUENCE OF AN INCREASED LEVEL OF ANDROGEN. IN COMBINATION WITH OTHER HORMONAL SUBSTANCES SUCH AS A STROGEN, TESTOSTERONE OR A STRONG ANDROGEN, THE COMPOUNDS OF THE INVENTION ARE APPROPRIATE AS CONTRACEPTIVE AND OTHER APPLICATIONS IN WOMEN AND MAN. |